EP Patent

EP0824533B1 — PYRAZOLO- 1,5a]-PYRIMIDINE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG

Assigned to BASF SE · Expires 2001-11-14 · 25y expired

What this patent protects

Patent listed against ponatinib-hydrochloride.

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: EP0824533B1
Jurisdiction: EP
Classification: —
Expires: 2001-11-14
Drug substance claim: No
Drug product claim: No
Assignee: BASF SE
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.